Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal)
Funding Amounts: $75,000 for one year
Summary: Supports fellows and early career faculty conducting innovative ovarian cancer research while developing research independence.
Key Information: Research must take place at a U.S. institution; non-SGO members need an SGO co-investigator or sponsor.
Description
The GSK Early Career Ovarian Cancer Research Grant is part of the Foundation for Women’s Cancer’s 2026–2027 Research Grants program. It supports promising fellows and early career faculty pursuing innovative ovarian cancer research, providing support during the transition to research independence. Applicants should demonstrate a strong commitment to a career in gynecologic oncology research and explain how the proposed work will advance their development as independent investigators.
Projects may encompass basic, translational, clinical, or population-based research relevant to the prevention, diagnosis, treatment, or outcomes of gynecologic cancers. Priority goes to innovative projects with the potential to generate preliminary data, catalyze future research, and attract extramural funding.
